Skip to main content
. Author manuscript; available in PMC: 2009 Jul 30.
Published in final edited form as: J Infect Dis. 2009 Mar 1;199(5):750–757. doi: 10.1086/596738

Table 2.

Lumefantrine susceptibility levels in chloroquine resistance transporter gene (pfcrt)–modified and control lines.

Line LMF IC50,
nmol/La
Recombinant Parental
line
PfCRT haplotype CQb ARTM
IC50,b
nmol/L
MQ
IC50,b
nmol/L


72 74 75 76 220 271 326 356 371 IC50, nmol/L Phenotype
GC03 85.5 ± 7.2 No C M N K A Q N I R 29.2 ± 2.0 Susc. 39.4 ± 6.9 52.6 ± 5.4

Dd2 55.2 ± 9.6 No C I E T S E S T I 195.1 ± 25.3 Res. 46.3 ± 7.6 46.8 ± 2.0

7G8 27.0 ± 4.1 No S M N T S Q D L R 140.4 ± 15.0 Res. 21.6 ± 6.3 9.6 ± 1.3

C2GC03 74.0 ± 7.7 Yes GC03 C M N K A Q N I R 22.9 ± 2.8 Susc. 39.1 ± 7.0 54.7 ± 1.5

C4Dd2 48.7 ± 4.3c Yes GC03 C I E T S E S T I 147.4 ± 13.3d Res. 12.6 ± 1.8d 33.1 ± 3.1d

C67G8 46.3 ± 4.6d Yes GC03 S M N T S Q D L R 126.9 ± 17.2d Res. 17.2 ± 3.0d 27.3 ± 3.4d

T76K-1Dd2 73.2 ± 10.5d Yes Dd2 C I E K S E S T I 22.1 ± 2.1d Susc. 40.4 ± 11.7 27.2 ± 8.0c

C-1Dd2 33.7 ± 5.0 Yes Dd2 C I E T S E S T I 160.7 ± 28.9 Res. 32.9 ± 6.6 36.9 ± 4.2

T76K-17G8 68.3 ± 11.7d Yes 7G8 C I E K S Q D L R 23.9 ± 4.6e Susc. 13.8 ± 3.2 3.6 ± 0.7

C-17G8 33.6 ± 5.5 Yes 7G8 S M N T S Q D L R 108.8 ± 15.9 Res. 7.4 ± 2.1 3.1 ± 0.9

NOTE. ARTM, artemisinin; CQ, chloroquine; LMF, lumefantrine; MQ, mefloquine; Res., resistant; Susc., susceptible.

a

LMF IC50 values are expressed as the mean value (±SE) for pfcrt–modified and control lines. Data were derived from 5–12 independent assays performed in duplicate. (Results from Mann-Whitney U tests compared mutants and recombinant controls).

b

CQ, ARTM, and MQ IC50 values (from at least 3 independent assays performed in duplicate) are expressed as the mean value (±SE) and are reproduced from [19] for the top 6 lines and from [20] for the bottom 4 lines.

c

P < .05.

d

P < .01.

e

P < .001.